Accueil>>Peptides>>ELA-32(human) TFA

ELA-32(human) TFA

Catalog No.GC65922

L'ELA-32 (humain) TFA est un puissant agoniste du récepteur de l'apéline de haute affinité (IC50 = 0,27 nM ; Kd = 0,51 nM). ELA-32 (humain) TFA ne présente aucune liaison GPR15 et GPR25. ELA-32 (humain) TFA active la voie PI3K/AKT et favorise l'auto-renouvellement des CSEh via la progression du cycle cellulaire et la traduction des protéines. ELA-32 (humain) TFA potentialise également le TGFβ ; voie, amorÇant les CSEh vers la lignée de l'endoderme. ELA-32 (humain) TFA stimule l'angiogenèse dans les cellules HUVEC.

Products are for research use only. Not for human use. We do not sell to patients.

ELA-32(human) TFA Chemical Structure

Taille Prix Stock Qté
10mg
882,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ELA-32(human) TFA is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) TFA exhibits no binding GPR15 and GPR25. ELA-32(human) TFA activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) TFA also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) TFA stimulates angiogenesis in HUVEC cells.

Avis

Review for ELA-32(human) TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ELA-32(human) TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.